الفهرس 
Relevant Anatomy and pathologyOnly 14 pages are availabe for public view
 |  | from | 106 |  |  |
| | | from | 106 | | |
Abstract
Background: Prostatic artery embolization is a minimally invasive, image guided therapy, that has been shown to be safe and effective in symptomatic relief of LUTS associated with BPH with minimal post procedural complications. It is a safer choice as compared to the usual surgical procedures used in this case with comparable results. Technical success is considered when selective prostatic arterial catheterization and embolization is achieved on at least one pelvic side. Sometimes cases can only undergo unilateral prostatic artery embolization due to marked tortuosity or atherosclerotic changes preventing bilateral prostatic artery catheterization. The aim of this study is to evaluate efficacy of unilateral prostatic artery
embolization in management of benign prostatic hyperplasia presented with clinically significant lower urinary tract symptoms. In our study unilateral prostatic artery embolization was performed on 7 patients with benign prostatic hyperplasia patients, (mean age of 67.7 years (range 58 - 80 years). The mean prostatic volume measured was 80.29 ml (range 52-122 ml). The mean score of lower urinary tract symptoms were IPSS = 21.67 and QOL = 4.86 (with range of IPSS 18-29 and QOL 4-6). One of them complained of urinary retention and had and an indwelling catheter 4 months before procedure. The mean prostatic volume measured was 80.29 ml (range 52-122 ml). The mean score of lower urinary tract symptoms were IPSS = 21.67 and QOL = 4.86 (with range of IPSS 18-29 and QOL 4-6).
Results: There are statistically significant differences (P values < 0.05) between (Prostate volume, postvoiding urine volume, International prostate symptom score and quality of life) before and after 6 months of Prostatic artery embolization.
Conclusion: Prostatic artery embolization is a safe and effective procedure in management of benign prostatic hyperplasia with satisfactory results even in unilateral prostatic artery embolization due to marked atherosclerosis or vessel tortuosity.